JOHNSON & JOHNSON

Average Profitability
32.57%
Insider Buys Quantity
4
Insider Buys Sum
$17.87M
Insider Sells Quantity
2
Insider Sells Sum
$97.02M

Insider Activity of JOHNSON & JOHNSON

According to the SEC Form 4 filings, JOHNSON & JOHNSON, being in a position of

  1. 10 percent owner at CVRx, Inc.,
    оver the last 12 months, has bought 0 shares, and sold 3725 shares for $96,142,
    over all time since 2024-02-16, has bought 0 shares, and sold 3725 shares for $96,142.

The largest purchase of all time was on 2016-08-16 and amounted to 583333 shares of Protagonist Therapeutics, Inc. for $7M.

The largest sale of all time was on 2015-06-08 and amounted to 2020530 shares of Nevro Corp. for $96.92M.

Biography of JOHNSON & JOHNSON

No biography is available at this moment.

2024-02-16SaleCVRx, Inc.
CVRX
10 percent owner
3,725
0.0203%
$25.81$96,142-57.73%
2016-08-16PurchaseProtagonist Therapeutics, Inc.
PTGX
10 percent owner
583,333
7.2004%
$12.00$7M+18.24%
2015-06-08SaleNevro Corp.
NVRO
10 percent owner
2.02M
7.9887%
$47.97$96.92M+15.28%
2015-03-18PurchaseMinerva Neurosciences, Inc.
NERV
10 percent owner
607,903
2.4657%
$4.93$3M-14.54%
2015-03-13PurchaseMinerva Neurosciences, Inc.
NERV
10 percent owner
1.22M
6.3714%
$5.29$6.43M+2.69%
2014-11-12PurchaseNevro Corp.
NVRO
10 percent owner
80,000
1.2919%
$18.00$1.44M+85.38%
Company
About Prismo.proNewsPrivacy PolicyTerms of ServiceContact Us
Investing Ideas
Dividend StocksBlue Chip StocksDefensive StocksGrowth StocksValue StocksCyclical StocksPenny Stocks
Stock Tools
Insiders ScreenerStocks ScreenerTop StocksList of All Stocks
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.